Roche Media Jan 27, 2026 Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist | PharmExec - Pharmaceutical Executive
Thermo Fisher Jan 27, 2026 THERMO FISHER SCIENTIFIC Q4 2025 Earnings Preview: Recent $TMO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
10x Genomics Blog Jan 27, 2026 Capsule Techs Expand Possibilities for Experiments on Single Cells - GenomeWeb
FierceBiotech Jan 27, 2026 Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets
FierceBiotech Jan 27, 2026 TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio